York Sun Investment Holding

Yorksun is a specialized medical technology company based in Beijing, China, that focuses on the research, development, and production of in vitro diagnostic (IVD) solutions. The company is particularly recognized for its expertise in point-of-care testing (POCT), offering a range of automated and semi-automated immunoassay analyzers designed for rapid clinical decision-making. Yorksun's product portfolio includes a wide variety of diagnostic kits targeting cardiovascular diseases, infectious diseases, inflammation, and metabolic disorders. Utilizing advanced technologies such as fluorescence immunochromatography and chemiluminescence, the company provides high-sensitivity testing for critical biomarkers like Troponin I and Procalcitonin. Yorksun serves a global customer base, including hospitals and laboratories, and maintains rigorous quality standards with multiple CE-certified products. The company continues to expand its diagnostic menu and platform capabilities to address evolving healthcare needs.